U.S. flag

An official website of the United States government

Filters

reset all
See more specimen types...
See more states

Other countries

Results: 21 to 40 of 73

Tests names and labsConditionsGenes, analytes, and microbesMethods

Invitae Cancer Screen

Labcorp Genetics (formerly Invitae) LabCorp
United States
16062
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae 78 Gene Actionable Disorders Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
22075
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®)

Ambry Genetics
United States
9090
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®)

Ambry Genetics
United States
8890
  • D Deletion/duplication analysis
  • R RNA analysis
  • C Sequence analysis of the entire coding region

CustomNext-Cancer®

Ambry Genetics
United States
9490
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CancerNext-Expanded®

Ambry Genetics
United States
8689
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Panel for Individualized Cancer Threatment

GeneKor MSA
Greece
1552
  • D Deletion/duplication analysis
  • X Mutation scanning of select exons
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Hereditary Gastric Cancer Panel

Genetic Services Laboratory University of Chicago
United States
1019
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Cancer Panel

PreventionGenetics, part of Exact Sciences
United States
122117
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Piebaldism and Familial Gastrointestinal Stromal Tumors (GISTs) via the KIT Gene

PreventionGenetics, part of Exact Sciences
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Familial Gastrointestinal Stromal Tumors (GISTs) via the PDGFRA Gene

PreventionGenetics, part of Exact Sciences
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

OncoGeneDx Custom Panel

GeneDx
United States
10382
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Primary Antibody Deficiency NGS Panel

Fulgent Genetics
United States
10237
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel

Fulgent Genetics
United States
17759
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Primary Immunodeficiency NGS Panel

Fulgent Genetics
United States
1048472
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Severe Combined Immunodeficiency NGS Panel

Fulgent Genetics
United States
33090
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Oxidative Phosphorylation Disorders NGS Panel

Fulgent Genetics
United States
416235
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Neurotransmitter Metabolism Deficiency NGS Panel

Fulgent Genetics
United States
85101
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Paraganglioma/Pheochromocytoma Panel

Baylor Genetics
United States
219
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

Hereditary Renal Cancer Panel

Baylor Genetics
United States
4113
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

Results: 21 to 40 of 73

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.